Vascular endothelial growth factor secretion from mesenteric adipose tissue and from creeping fat in Crohn's disease

Journal of Gastroenterology and Hepatology (Australia)

Volumn 21, Issue 9, 2006, Pages 1419-1423

  Schäffler, Andreas ^a   Fürst, Alois ^a   Büchler, Christa ^a   Paul, Gisela ^a   Rogler, Gerhard ^a   Schölmerich, Jürgen ^a   Herfarth, Hans ^a  

^a UNIVERSITY OF REGENSBURG   (Germany)

Author keywords

Adipose tissue; Creeping fat; Crohn's disease; Inflammatory bowel disease; VEGF

Indexed keywords

ADIPOCYTOKINE; CHEMOKINE; CORTICOSTEROID; GROWTH FACTOR; ROSIGLITAZONE; STEROID; TROGLITAZONE; VASCULOTROPIN;

ADIPOSE TISSUE; ARTICLE; CLINICAL ARTICLE; COLON CANCER; CROHN DISEASE; DIVERTICULITIS; ENTERITIS; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; HUMAN; HUMAN TISSUE; INFLAMMATION; MALE; MESENTERY; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN SECRETION; SUPERNATANT;

EID: 33746628465     PISSN: 08159319     EISSN: 14401746     Source Type: Journal    
DOI: 10.1111/j.1440-1746.2006.04301.x     Document Type: Article

References (30)

1. Ribatti D. The crucial role of vascular permeability factor/vascular endothelial growth factor in angiogenesis: a historical review. Br. J. Haematol. 2005; 128: 303-9.
2. Di Sabatino A, Ciccocioppo R, Armellini E et al. Serum bFGF and VEGF correlate respectively with bowel wall thickness and intramural blood flow in Crohn's disease. Inflamm. Bowel Dis. 2004; 10: 573-7.
3. Kanazawa S, Tsunoda T, Onuma E, Majima T, Kagiyama M, Kikuchi K. VEGF, basic-FGF, and TGF-beta in Crohn's disease and ulcerative colitis: a novel mechanism of chronic intestinal inflammation. Am. J. Gastroenterol. 2001; 96: 822-8.
4. Griga T, Tromm A, Spranger J, May B. Increased serum levels of vascular endothelial growth factor in patients with inflammatory bowel disease. Scand. J. Gastroenterol. 1998; 33: 504-8.
5. Bousvaros A, Leichtner A, Zurakowski D et al. Elevated serum vascular endothelial growth factor in children and young adults with Crohn's disease. Dig. Dis. Sci. 1999; 44: 424-30.
6. Di Sabatino A, Ciccocioppo R, Benazzato L, Sturniolo GC, Corazza GR. Infliximab downregulates basic fibroblast growth factor and vascular endothelial growth factor in Crohn's disease patients. Aliment. Pharmacol. Ther. 2004; 19: 1019-24.
7. Magro F, Araujo F, Pereira P, Meireles E, Diniz-Ribeiro M, Velosom FT. Soluble selectins, sICAM, sVCAM, and angiogenic proteins in different activity groups of patients with inflammatory bowel disease. Dig. Dis. Sci. 2004; 49: 1265-74.
8. Griga T, Gutzeit A, Sommerkamp C, May B. Increased production of vascular endothelial growth factor by peripheral blood mononuclear cells in patients with inflammatory bowel disease. Eur. J. Gastroenterol. Hepatol. 1999; 11: 175-9.
9. Griga T, May B, Pfisterer O, Muller KM, Brasch F. Immunohistochemical localization of vascular endothelial growth factor in colonic mucosa of patients with inflammatory bowel disease. Hepatogastroenterology 2002; 49: 116-23.
10. Griga T, Voigt E, Gretzer B, Brasch F, May B. Increased production of vascular endothelial growth factor by intestinal mucosa of patients with inflammatory bowel disease. Hepatogastroenterology 1999; 46: 920-3.
11. Beddy D, Watson RW, Fitzpatrick JM, O'Connel PR. Increased vascular endothelial growth factor production in fibroblasts isolated from strictures in patients with Crohn's disease. Br. J. Surg. 2004; 91: 72-7.
12. Morimura M, Ishiko O, Sumi T, Yoshida H, Ogita S. Angiogenesis in adipose tissues and skeletal muscles with rebound weight gain after diet-restriction in rabbits. Int. J. Mol. Med. 2001; 8: 499-503.
13. Mick GJ, Wang X, McCormick K. White adipocyte vascular endothelial growth factor: regulation by insulin. Endocrinology 2002; 143: 948-53.
14. Emoto M, Anno T, Sato Y et al. Trogliatzone treatment increases plasma vascular endothelial growth factor in diabetic patients and its mRNA in 3T3-L1 adipocytes. Diabetes 2001; 50: 1166-70.
15. Lolmede K, Durand de Saint Front V, Galitzky J, Lafontan M, Bouloumie A. Effects of hypoxia on the expression of proangiogenic factors in differentiated 3T3-F442A adipocytes. Int. J. Obes. Metab. Disord. 2003; 27: 1187-95.
16. Fain JN, Madan AK, Hiler ML, Cheema P, Bahouth SW. Comparison of the release of adipokines by adipose tissue, adipose tisssue matrix, and adipocytes from visceral and subcutaneous abdominal adipose tissue of obese humans. Endocrinology 2004; 145: 2273-82.
17. Miyazawa-Hoshimoto S, Takahashi K, Bujo H, Hashimoto N, Yagui K, Saito Y. The roles of degree of fat deposition and its localization on VEGF expression in adipocytes. Am. J. Physiol. Endocrinol. Metab. 2004; 288: E1128-36.
18. Hausmann GJ, Richardson RL. Adipose tissue angiogenesis. J. Anim. Sci. 2004; 82: 925-34.
19. Li X, Jin L, Cui Q, Wang GJ, Balian G. Steroid effects on osteogenesis through mesenchymal cell gene expression. Osteoporos. Int. 2005; 16: 101-8.
20. Ahima RS, Flier JS. Adipose tissue as an endocrine organ. Trends Endocrinol. Metab. 2000; 11: 327-32.
21. Shimomura I, Funahashi T, Takahashi M et al. Enhanced expression of PAI-1 in visceral fat: possible contributor to vascular disease in obesity. Nat. Med. 1996; 2: 800-3.
22. Xu H, Barnes GT, Yang Q et al. Chronic inflammation in fat plays a crucial role in the development of obesity-related insulin resistance. J. Clin. Invest. 2003; 112: 1821-30.
23. Weisberg SP, McCann D, Desai M, Rosenbaum M, Leibel RL, Ferrante AW Jr. Obesity is associated with macrophage accumulation in adipose tissue. J. Clin. Invest. 2003; 112: 1796-808.
24. Desreumaux P, Ernst O, Geboes K et al. Inflammatory alterations in mesenteric adipose tissue in Crohn's disease. Gastroenterology 1999; 117: 73-81.
25. Barbier M, Vidal H, Desreumaux P et al. Overexpression of leptin mRNA in mesenteric adipose tissue in inflammatory bowel diseaseas. Gastroenterol. Clin. Biol. 2003; 27: 987-91.
26. Rogler G, Gelbmann CM, Vogl D et al. Differential activation of cytokine secretion in primary human colonic fibroblast/myofibroblast cultures. Scand. J. Gastroenterol. 2001; 36: 389-98.
27. Colombel JF, Dubuquoy L, Sandborn WJ et al. The adipose tissue as a source of proinflammatory signals in Crohn's disease? In: Herfarth H, Feagan BG, Fölsch UR, Schölmerich J, Vatn MH, Zeitz M, eds. Targets of Treatment in Chronic Inflammatory Bowel Diseases. London: Kluwer Academic Publishers, 2002; 99-104.
28. Bujalska IJ, Kumar S, Stewart PM. Does central obesity reflect 'Cushings disease of the omentum'? Lancet 1997; 349: 1210-13.
29. Leal-Cerro A, Soto A, Martinez MA, Dieguez C, Casanueva FF. Influence of cortisol status on leptin secretion. Pituitary 2001; 4: 111-16.
30. Askari H, Liu J, Dagogo-Jack S. Hormonal regulation of human leptin in vivo: effects of hydrocortisone and insulin. Int. J. Obes. Relat. Metab. Disord. 2000; 24: 1254-9.